Home »
2024 Issues »
89 FR (10/15/2024) » 2024-23716. Endosseous Dental Implants and Endosseous Dental Implant Abutments-Performance Criteria for Safety and Performance Based Pathway; Guidance for Industry and Food and Drug Administration Staff; Availability
2024-23716. Endosseous Dental Implants and Endosseous Dental Implant Abutments-Performance Criteria for Safety and Performance Based Pathway; Guidance for Industry and Food and Drug Administration Staff; Availability
| 21 CFR part; guidance; or FDA form |
Topic |
OMB Control No. |
| 807, subpart E |
Premarket notification |
0910-0120 |
| “Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program” |
Q-submissions and Early Payor Feedback Request Programs for Medical Devices |
0910-0756 |
Document Information
- Published:
- 10/15/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice of availability.
- Document Number:
- 2024-23716
- Dates:
- The announcement of the guidance is published in the Federal Register on October 15, 2024.
- Pages:
- 83019-83020 (2 pages)
- Docket Numbers:
- Docket No. FDA-2024-D-4409
- PDF File:
-
2024-23716.pdf
